세계의 체외진단(IVD) 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2033년)

Global In Vitro Diagnostics Market size is anticipated to grow from USD 89.64 Billion in 2024 to USD 126.16 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 3.87% during the forecast period of 2026 to 2033.

The in vitro diagnostics (IVD) market is poised for substantial growth, driven by the increasing prevalence of chronic diseases and the rising demand for early and accurate diagnostic solutions. IVD tests, which are performed on samples such as blood, urine, and tissue, play a critical role in disease detection, monitoring, and management. As healthcare providers increasingly prioritize personalized medicine and preventive care, the demand for advanced IVD technologies is expected to rise. Innovations in molecular diagnostics, point-of-care testing, and automation are enhancing the accuracy and efficiency of diagnostic processes, further propelling market growth.

Technological advancements in IVD are also shaping the future of this market. The development of rapid testing methods and the integration of artificial intelligence and machine learning in data analysis are revolutionizing the way diagnostics are performed. These innovations enable healthcare professionals to obtain timely results, facilitating quicker decision-making and improved patient outcomes. Additionally, the growing trend towards home-based testing and telemedicine is likely to influence the IVD market positively, as patients seek convenient and accessible diagnostic solutions.

Moreover, the expansion of healthcare infrastructure in emerging economies is expected to positively impact the in vitro diagnostics market. As access to healthcare improves and the demand for quality diagnostic services increases in regions such as Asia-Pacific and Latin America, the consumption of IVD products will rise. Companies that focus on developing innovative and cost-effective diagnostic solutions tailored to specific regional needs will be well-positioned to capture market share. As the IVD market evolves, the interplay of technological advancements, regulatory changes, and shifting consumer preferences will create a dynamic environment ripe with opportunities for growth and innovation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

• Instruments
• Reagents
• Software
• Services

By Technology

• Immunoassay
• Clinical Chemistry
• Molecular Diagnostics
• Hematology
• Microbiology
• Coagulation
• Others

By Application

• Infectious Diseases
• Oncology
• Cardiology
• Nephrology
• Autoimmune Diseases
• Others

By End-User

• Hospitals
• Diagnostic Laboratories
• Academic and Research Institutes
• Others
• COMPANIES PROFILED
• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Danaher Corporation
• Thermo Fisher Scientific
• Becton
• Dickinson and Company (BD)
• Bio-Rad Laboratories
• bioMA(C)rieux
• Qiagen
• Hologic
• Sysmex Corporation
• Ortho Clinical Diagnostics
• Agilent Technologies
• Illumina"
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. IN VITRO DIAGNOSTICS INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Technology
  • 3.7.3 Market Attractiveness Analysis By Application
  • 3.7.4 Market Attractiveness Analysis By End-User
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE

• 5.1. Overview By Product Type
• 5.2. Historical and Forecast Data Analysis By Product Type
• 5.3. Instruments Historic and Forecast Sales By Regions
• 5.4. Reagents Historic and Forecast Sales By Regions
• 5.5. Software Historic and Forecast Sales By Regions
• 5.6. Services Historic and Forecast Sales By Regions

6. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

• 6.1. Overview By Technology
• 6.2. Historical and Forecast Data Analysis By Technology
• 6.3. Immunoassay Historic and Forecast Sales By Regions
• 6.4. Clinical Chemistry Historic and Forecast Sales By Regions
• 6.5. Molecular Diagnostics Historic and Forecast Sales By Regions
• 6.6. Hematology Historic and Forecast Sales By Regions
• 6.7. Microbiology Historic and Forecast Sales By Regions
• 6.8. Coagulation Historic and Forecast Sales By Regions
• 6.9. Others Historic and Forecast Sales By Regions

7. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

• 7.1. Overview By Application
• 7.2. Historical and Forecast Data Analysis By Application
• 7.3. Infectious Diseases Historic and Forecast Sales By Regions
• 7.4. Oncology Historic and Forecast Sales By Regions
• 7.5. Cardiology Historic and Forecast Sales By Regions
• 7.6. Nephrology Historic and Forecast Sales By Regions
• 7.7. Autoimmune Diseases Historic and Forecast Sales By Regions
• 7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY END-USER

• 8.1. Overview By End-User
• 8.2. Historical and Forecast Data Analysis By End-User
• 8.3. Hospitals Historic and Forecast Sales By Regions
• 8.4. Diagnostic Laboratories Historic and Forecast Sales By Regions
• 8.5. Academic and Research Institutes Historic and Forecast Sales By Regions
• 8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE IN VITRO DIAGNOSTICS COMPANIES

• 10.1. In Vitro Diagnostics Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF IN VITRO DIAGNOSTICS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Roche Diagnostics
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Abbott Laboratories
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Siemens Healthineers
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Danaher Corporation
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Thermo Fisher Scientific
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Becton
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Dickinson And Company (BD)
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Bio-Rad Laboratories
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. BioMAfA(C)Rieux
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Qiagen
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments
• 11.13. Hologic
  • 11.13.1 Company Overview
  • 11.13.2 Company Revenue
  • 11.13.3 Products
  • 11.13.4 Recent Developments
• 11.14. Sysmex Corporation
  • 11.14.1 Company Overview
  • 11.14.2 Company Revenue
  • 11.14.3 Products
  • 11.14.4 Recent Developments
• 11.15. Ortho Clinical Diagnostics
  • 11.15.1 Company Overview
  • 11.15.2 Company Revenue
  • 11.15.3 Products
  • 11.15.4 Recent Developments
• 11.16. Agilent Technologies
  • 11.16.1 Company Overview
  • 11.16.2 Company Revenue
  • 11.16.3 Products
  • 11.16.4 Recent Developments
• 11.17. Illumina"
  • 11.17.1 Company Overview
  • 11.17.2 Company Revenue
  • 11.17.3 Products
  • 11.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies